Analyst Price Targets — SMLR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2025 10:14 am | Brett Knoblauch | Cantor Fitzgerald | $61.00 | $38.08 | TheFly | Semler Scientific initiated with an Overweight at Cantor Fitzgerald |
| May 29, 2024 8:40 am | Brooks O'Neil | Loop Capital Markets | $40.00 | $32.72 | StreetInsider | Semler Scientific (SMLR) PT Lowered to $40 at Lake Street Capital Markets |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for SMLR

New York, New York--(Newsfile Corp. - January 22, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Semler Scientific (NASDAQ: SMLR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Semler Scientific caused the company to misrepresent or fail to disclose that: (1) Semler Scientific did not…

Semler Scientific Inc. (NASDAQ: SMLR - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price

Generali Asset Management SPA SGR lifted its position in Semler Scientific Inc. (NASDAQ: SMLR) by 42.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 100,000 shares of the company's stock after buying an additional 30,000 shares during the quarter. Generali Asset Management

Semler Scientific Inc. (NASDAQ: SMLR - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target

Semler Scientific (NASDAQ: SMLR - Get Free Report) and Vasamed (OTCMKTS:VSMD - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Earnings and Valuation This table compares Semler Scientific and
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SMLR.
U.S. House Trading
No House trades found for SMLR.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
